SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (547)2/11/1999 11:41:00 PM
From: Larry Liebman  Read Replies (2) | Respond to of 1073
 
Richard: Off the topic

I have a brilliant 17 year old niece. 800 S.A.T.'s, National Merit finalist, valedictorian, etc., etc.(and an incredibly good kid to boot!). She wants to be a virologist. Where would you go to school?
Any other biotech freaks, feel free to respond!



To: scaram(o)uche who wrote (547)2/12/1999 10:55:00 PM
From: 5,17,37,5,101,...  Read Replies (2) | Respond to of 1073
 
Yes, a EGFr competitor. But CP-358 is way behind C225 which soon will be in PIII.

If Oncogene/Pfizer were in PIII Pfizer stock would rise dramatically. Why is IMCL stock not responding? That's my real question to which I have no answer except skepticism of market efficiency or of IMCL product.

Thanks for the cue.

Jackson


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News